Role of adjuvant therapy in surgically resected colorectal carcinoma
- 30 September 1995
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 109 (3) , 984-993
- https://doi.org/10.1016/0016-5085(95)90410-7
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative SurgeryNew England Journal of Medicine, 1994
- Adjuvant Therapy for Stage III Colon Cancer: Economics Returns to Research and Cost-Effectiveness of TreatmentJNCI Journal of the National Cancer Institute, 1994
- Staging of cancer of the colon and rectumCancer, 1992
- NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancerJAMA, 1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Adjuvant therapy of colorectal cancer. Why we still don't knowPublished by American Medical Association (AMA) ,1988
- Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-ccnu following resection for carcinoma of the large bowel. A veterans administration surgical oncology group reportCancer, 1984
- Adjuvant Chemotherapy in Cancer of the Colon and Rectum: Demonstration of Effectiveness of Prolonged 5-FU Chemotherapy in a Prospectively Controlled, Randomized TrialSurgical Clinics of North America, 1981
- Fudr as an adjuvant to surgery in cancer of the large bowelJournal of Surgical Oncology, 1973
- The Use of 5-Fluorodeoxy uridine (FUDR) as a Surgical Adjuvant in Carcinoma of the Stomach and ColorectumArchives of Surgery, 1963